Vaccine Immunology or Immunotherapy and Epidemiology

Patients with safe mediated incendiary ailments (for example, IBD, RA or psoriasis, are at increased risk of contamination, in part in light of the malady itself, however for the most part in light of treatment with immunomodulatory or immunosuppressive medications. Regardless of their raised hazard for vaccination preventable disease, immunization scope in IMID patients is shockingly low.

  • Vaccines for immunodeficiency diseases
  • Epidemiology
  • Vaccination strategy in patients with IMID
  • Vaccines for autoimmune skin disorders
  • Innate immunity and diabetes vaccines

Related Conference of Vaccine Immunology or Immunotherapy and Epidemiology

July 29-30 2019

6th International Conference on Parasitology & Microbiology

Amsterdam, Netherlands
July 29-30, 2019

11th Global Summit on Immunology and Cell Biology

Sydney, Australia
November 12-13, 2019

13th International Congress on Autoimmunity

Brisbane, Australia
November 14-15, 2019

International Conference on Vaccines and Immune Response

Istanbul, Turkey
November 14-15, 2019

Annual Congress on Antibiotics and Antimicrobial Resistance

Geneva, Switzerland
November 21-22, 2019

World Conference on Vaccine and Immunology

Dubai, UAE

Vaccine Immunology or Immunotherapy and Epidemiology Conference Speakers

Recommended Sessions

Related Journals

Are you interested in